Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Back
Poster session
PoS 3
ePoster 02
Appointment
Date:
05.12.
Time:
17:00
–
18:30
Location / Stream:
ePoster station 2
Programme
ePoster
P196
Migraine under treatment: Findings from the Americas' Migraine Observatory Study (AMIGOS)
Marco Lisicki (Córdoba, AR)
ePoster
P197
MultiHEAD – work-focused multidisciplinary headache treatment
Oda Vardenær Lunder (Oslo, NO)
ePoster
P198
Migraine epidemiology in Israel – a retrospective database study
Matanya Tirosh (Herzliya, IL)
Danna Davidovici (Herzliya, IL)
ePoster
P199
Examining trajectories of functional disability – a post-hoc analysis of Zavegepant
Jessica Cirillo (New York, US)
ePoster
P200
Clinical characteristics and outcomes of status migrainosus in a tertiary hospital
Gonçalo Cabral (Lisboa, PT)
ePoster
P201
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like sensitivity without motor impairment in FHM1 and WT mice
Georgii Krivoshein (Leiden, NL)
ePoster
P202
Long-term effectiveness of eptinezumab in patients with migraine and 2-4 prior preventive treatment failures who self-reported psychiatric comorbidities at screening
Patricia Pozo-Rosich (Barcelona, ES)
ePoster
P203
Contemporary prospective understanding of migraine real-world evidence (CAPTURE): baseline migraine treatment patterns
Laurent Delahaye (Rungis, FR)
ePoster
P204
Efficacy of fremanezumab treatment for migraine prevention in patients with migraine and major depressive disorder: results from the open-label extension of the UNITE study
Piero Barbanti (Rome, IT)
ePoster
P205
White matter hyperintensities in a Portuguese cohort of migraine patients: prevalence, characterization and clinical correlations
Stefanie Moreira (Braga, PT)
ePoster
P206
Risk factors for migraine onset – a systematic review and three-level meta-analysis
Maria Terhart (Berlin, DE)
ePoster
P207
Long-term outcomes (over 24 months) of anti-CGRP therapy in migraine – a real-world single-center study
Mariana Henriques (Lisboa, PT)
ePoster
P208
Electrophysiological disparities in trigeminal ganglion neurons induced by serotonin depletion: Implications for migraine in rats model
Sirikorn Vongseenin (Bangkok, TH)
ePoster
P209
Comparison of brain structural MRI before and after 6-months of preventive treatment with anti-CGRP monoclonal antibodies and onabotulinumtoxinA in people with migraine
Joana Rosell-Mirmi (Barcelona, ES)
ePoster
P210
Is migraine a severity predictor in CADASIL patients? Early results from CADA-Migraine study
Danilo Antonio Montisano (Milan, IT)
ePoster
P211
Analysis of serum alpha-CGRP levels in different disorders and its meaning regarding the specificity of increased concentrations of the peptide for chronic migraine
Gabriel Gárate (Santander, ES)
ePoster
P212
Impact of Atogepant on long-term response rates and migraine-specific quality of life in migraine prevention: interim analysis of a phase 3, multicenter, open-label, 156-week extension study
Peter J. Goadsby (London, UK)
Jonathan H. Smith (North Chicago, US)
ePoster
P213
Psychiatric comorbidities in migraine patients and the influence of monoclonal antibody therapy against CGRP – preliminary results
Catarina Fernandes (Coimbra, PT)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy